Fernando Meton de Alencar Câmara Vieira

Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2

Mauro Zukin, Carlos H. Barrios, José Rodrigues Pereira et al. · Journal of Clinical Oncology · 2013 · 237 citations

Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study

Rodrigo Otávio Araújo, Marcus Valadão, Daniel Lago Borges et al. · European Journal of Surgical Oncology · 2015 · 141 citations

Surgical Oncology, Radiation Therapy, Gastrointestinal Oncology +11

Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

Luis O. Olivatto, Fernando Meton de Alencar Câmara Vieira, Bruno Vilhena Pereira et al. · Cancer · 2013 · 66 citations · Full text

KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients

Carlos Gil Ferreira, Veronica Aran, Ilana Zalcberg-Renault et al. · BMC Gastroenterology · 2014 · 41 citations · Full text

A randomized phase III trial of single-agent pemetrexed (P) versus carboplatin and pemetrexed (CP) in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2.

Rogério Lilenbaum, Mauro Zukin, José Rodrigues Pereira et al. · Journal of Clinical Oncology · 2012 · 27 citations

Cancer Management, Oncology, Metronomic Therapy +16